Skip to main content
. 2022 May 7;11(9):1564. doi: 10.3390/cells11091564

Table 9.

Results of inBio Discover annotation analysis with disease ontology annotations of diseases (DOID) performed on the upregulated differentially expressed proteins (DEPs) of adverse childhood experiences.

Term ID all DEPs DOID Annotations Size Overlap Enrichment FDR
DOID:0060032 Autoimmune disease of musculoskeletal system 645 91/342 8.25 1.4 × 10−57
DOID:848 Arthritis 481 79/342 9.60 7.9 × 10−55
DOID: 3342 Bone inflammation disease 501 80/342 9.34 1.5 × 10−54
DOID:2914 Immune system disease 1.9 k 139/342 4.28 4.5 × 10−54
DOID:0050589 Inflammatory bowel disease 306 66/342 12.61 1.3 × 10−53
DOID:7148 Rheumatoid arthritis 313 65/342 12.14 1.1 × 10−51
DOID:612 Primary immunodeficiency disease 1.3 k 115/342 5.06 7.4 × 10−51
DOID:417 Autoimmune disease 1.1 k 104/342 5.70 1.9 × 10−50
DOID:65 Connective tissue disease 1.8 k 128/342 4.06 1.6 × 10−46
DOID:8893 Psoriasis 189 50/342 15.47 2.5 × 10−45
Term ID all DEPs Custom Term Annotations Size Overlap Enrichment FDR p
DOID: 3213 Demyelinating disease 218 42/342 11.27 5.8 × 10−32
DOID:1936 Atherosclerosis 352 34/342 5.65 3.1 × 10−16
DOID: 936 Brain Disease 1.5 k 59/342 2.29 1.5 × 10−9
WP 1455 Serotonin transported activity 11 3/342 15.95 7.4 × 10−4
GO:1901215 Negative regulation of neuron death 65 5/342 4.50 5.1 × 10−3
GO:1903978 Regulation of microglial cell activation 6 2/342 19.49 4.2 × 10−3

Term ID: term identification; FDR: false discovery rate.